CellCarta Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 1,000

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 10

CellCarta General Information

Description

Operator of a contract research organization laboratory intended for the pharmaceutical and biotechnology industries. The company specializes in proteomics and immune monitoring that offer proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses and proteomics testing, enabling clients with a comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Contact Information

Formerly Known As
Caprion Proteomics, Caprion Proteomics GP, Caprion-HistoGeneX, Caprion Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 201 President Kennedy Avenue
  • Suite 3900
  • Montreal, Quebec H2X 3Y7
  • Canada
+1 (514)
Primary Industry
BPO/Outsource Services
Vertical(s)
Corporate Office
  • 201 President Kennedy Avenue
  • Suite 3900
  • Montreal, Quebec H2X 3Y7
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellCarta Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CellCarta‘s full profile, request access.

Request a free trial

CellCarta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a contract research organization laboratory intended for the pharmaceutical and biotechnology industries. Th
BPO/Outsource Services
Montreal, Canada
1,000 As of 2025

Markham, Canada
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CellCarta Competitors (3)

One of CellCarta’s 3 competitors is Everest Clinical Research, a Private Equity-Backed company based in Markham, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Everest Clinical Research Private Equity-Backed Markham, Canada
Meso Scale Diagnostics Corporation Rockville, MD
PeproTech Corporate Backed or Acquired Cranbury, NJ
You’re viewing 3 of 3 competitors. Get the full list »

CellCarta Patents

CellCarta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10935549-B2 Biomarkers of latent tuberculosis infection Active 14-Jul-2016
US-20190277846-A1 Biomarkers of latent tuberculosis infection Active 14-Jul-2016
WO-2018013883-A1 Biomarkers of latent tuberculosis infection Inactive 14-Jul-2016
WO-2018013883-A8 Biomarkers of latent tuberculosis infection Inactive 14-Jul-2016
AU-2014233935-A1 Brucellosis, q-fever, and lyme disease biomarkers and uses thereof Inactive 21-Mar-2013 G01N33/6848
To view CellCarta’s complete patent history, request access »

CellCarta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellCarta Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CellCarta‘s full profile, request access.

Request a free trial

CellCarta Investments (10)

CellCarta’s most recent deal was a Buyout/LBO with Precision Assays (Commercial Rights To Immuno-MRM Assays). The deal was made on 17-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Assays (Commercial Rights To Immuno-MRM Assays) 17-May-2022 Buyout/LBO Buildings and Property
Biogazelle 14-Dec-2021 Buyout/LBO Other Pharmaceuticals and Biotechnology
Reveal Biosciences 11-May-2021 Buyout/LBO Discovery Tools (Healthcare)
Mosaic Laboratories 12-Jan-2021 Buyout/LBO Biotechnology
Clinical Logistics 07-Jan-2021 Buyout/LBO Medical Supplies
You’re viewing 5 of 10 investments. Get the full list »

CellCarta Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Mosaic Laboratories Lake Forest, CA 2005
Histogenex Antwerp, Belgium 2001

CellCarta FAQs

  • When was CellCarta founded?

    CellCarta was founded in 2000.

  • Where is CellCarta headquartered?

    CellCarta is headquartered in Montreal, Canada.

  • What is the size of CellCarta?

    CellCarta has 1,000 total employees.

  • What industry is CellCarta in?

    CellCarta’s primary industry is BPO/Outsource Services.

  • Is CellCarta a private or public company?

    CellCarta is a Private company.

  • What is the current valuation of CellCarta?

    The current valuation of CellCarta is .

  • What is CellCarta’s current revenue?

    The current revenue for CellCarta is .

  • Who are CellCarta’s investors?

    Arsenal Capital Partners has invested in CellCarta.

  • Who are CellCarta’s competitors?

    Everest Clinical Research, Meso Scale Diagnostics, and PeproTech are competitors of CellCarta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process